These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 304199)

  • 1. Pathologic aspects of chemotherapy response in the treatment of osteogenic sarcoma. An analysis of two cases.
    Marroum MC; Huvos AG; Rosen G
    Oncology; 1977; 34(6):273-80. PubMed ID: 304199
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemotherapy, en bloc resection, and prosthetic bone replacement in the treatment of osteogenic sarcoma.
    Rosen G; Murphy ML; Huvos AG; Gutierrez M; Marcove RC
    Cancer; 1976 Jan; 37(1):1-11. PubMed ID: 1082364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Primary osteogenic sarcoma: pathologic aspects in 20 patients after treatment with chemotherapy en bloc resection, and prosthetic bone replacement.
    Huvos AG; Rosen G; Marcove RC
    Arch Pathol Lab Med; 1977 Jan; 101(1):14-8. PubMed ID: 299812
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic factors in the response of primary osteogenic sarcoma to preoperative chemotherapy (high-dose methotrexate with citrovorum factor).
    Juergens H; Kosloff C; Nirenberg A; Mehta BM; Huvos AG; Rosen G
    Natl Cancer Inst Monogr; 1981 Apr; (56):221-6. PubMed ID: 6975439
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Preoperative chemotherapy for osteogenic sarcoma: selection of postoperative adjuvant chemotherapy based on the response of the primary tumor to preoperative chemotherapy.
    Rosen G; Caparros B; Huvos AG; Kosloff C; Nirenberg A; Cacavio A; Marcove RC; Lane JM; Mehta B; Urban C
    Cancer; 1982 Mar; 49(6):1221-30. PubMed ID: 6174200
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of high-dose methotrexate with citrovorum factor "rescue" in the treatment of osteogenic sarcoma.
    Jaffe N; Traggis D; Cassady JR; Filler RM; Watts H; Frei E
    Int J Radiat Oncol Biol Phys; 1977; 2(3-4):261-6. PubMed ID: 301137
    [No Abstract]   [Full Text] [Related]  

  • 7. The management of pulmonary metastases in children with osteogenic sarcoma with surgical resection combined with chemotherapy.
    Beattie EJ; Martini N; Rosen G
    Cancer; 1975 Mar; 35(3):618-21. PubMed ID: 1078639
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Telangiectatic osteogenic sarcoma. Improved survival with combination chemotherapy.
    Rosen G; Huvos AG; Marcove R; Nirenberg A
    Clin Orthop Relat Res; 1986 Jun; (207):164-73. PubMed ID: 2424660
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Primary osteogenic sarcoma: the rationale for preoperative chemotherapy and delayed surgery.
    Rosen G; Marcove RC; Caparros B; Nirenberg A; Kosloff C; Huvos AG
    Cancer; 1979 Jun; 43(6):2163-77. PubMed ID: 88251
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adjuvant chemotherapy for osteogenic sarcoma.
    Etcubanas E; Wilbur JR
    Cancer Treat Rep; 1978 Feb; 62(2):283-7. PubMed ID: 346218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selected applications of methotrexate alone and in combination in osteosarcoma.
    Pratt CB
    Cancer Treat Rep; 1981; 65 Suppl 1():107-11. PubMed ID: 6976828
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High-dose methotrexate with citrovorum factor rescue and adriamycin in childhood osteogenic sarcoma.
    Rosen G; Suwansirikul S; Kwon C; Tan C; Wu SJ; Beattie EJ; Murphy ML
    Cancer; 1974 Apr; 33(4):1151-63. PubMed ID: 4544836
    [No Abstract]   [Full Text] [Related]  

  • 13. Osteogenic sarcoma: eight-percent, three-year, disease-free survival with combination chemotherapy (T-7).
    Rosen G; Nirenberg A; Caparros B; Juergens H; Kosloff C; Mehta BM; Marcove RC; Huvos AG
    Natl Cancer Inst Monogr; 1981 Apr; (56):213-20. PubMed ID: 6946291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neo-adjuvant therapy in childhood osteogenic sarcoma: a pilot study of selective postoperative chemotherapy based on response to preoperative high-dose methotrexate].
    Sasaki K; Matsuoka H; Murakami T; Fujimoto T; Takayanagi F; Sawai K; Niwa J; Hara K
    Gan To Kagaku Ryoho; 1986 May; 13(5):1837-45. PubMed ID: 3486634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination chemotherapy and radiation therapy in the treatment of metastatic osteogenic sarcoma.
    Rosen G; Tefft M; Martinez A; Cham W; Murphy ML
    Cancer; 1975 Mar; 35(3):622-30. PubMed ID: 1078640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The rationale for multiple drug chemotherapy in the treatment of osteogenic sarcoma.
    Rosen G; Tan C; Sanmaneechai A; Beattie EJ; Marcove R; Murphy ML
    Cancer; 1975 Mar; 35(3 suppl):936-45. PubMed ID: 1078642
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adjuvant multiple drug chemotherapy for osteosarcoma of the extremity.
    Pratt C; Shanks E; Hustu O; Rivera G; Smith J; Kumar AP
    Cancer; 1977 Jan; 39(1):51-7. PubMed ID: 299829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High-dose methotrexate and adriamycin in osteogenic sarcoma: the children's hospital of Philadelphia study.
    Lange B; Kramer S; Gregg JR; Toledano S; Wimmer R; Evans AE
    Am J Clin Oncol; 1982 Feb; 5(1):3-8. PubMed ID: 6979238
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy of malignant fibrous histiocytoma of bone. A report of five cases.
    Urban C; Rosen G; Huvos AG; Caparros B; Cacavio A; Nirenberg A
    Cancer; 1983 Mar; 51(5):795-802. PubMed ID: 6295615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The potential for an improved prognosis with chemotherapy in osteogenic sarcoma.
    Jaffe N
    Clin Orthop Relat Res; 1975; (113):111-8. PubMed ID: 1081438
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.